Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPOT Sign selection of intracerebral hemorrhage to guide hemostatic therapy
ISRCTN29749408Phase 2Completed
- Sponsor
- Sunnybrook Research Institute
- Start
- Jan 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in intracerebral hemorrhage (ICH) comparing rFVIIa arm with Placebo arm (2 arms). Started Jan 2011; status: completed.
02
Drugs
Coagulation factor VIIa recombinant human
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on ISRCTN29749408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN29749408.